Both in Pharmaceuticals
Enanta Pharmaceuticals vs Prelude Therapeutics Incorporated
Over the past year ENTA returned +4.3% and PRLD returned +164.6%; their daily moves had a correlation of 0.12.
ENTA +4.3% PRLD +164.6%Growth of $1, one year, split-adjusted
| Metric | ENTA | PRLD |
|---|---|---|
| Price | $10.92 | $4.08 |
| Market cap | $318.0M | $325.2M |
| Today | −5.45% | −1.57% |
| 1 month | −17.1% | +4.2% |
| 6 months | −21.4% | −22.1% |
| Year to date | −30.8% | +40.5% |
| 1 year | +4.3% | +164.6% |
| Revenue growth (YoY) | −21.6% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −135.8% | −244.1% |
| P/E (TTM) | — | — |
| Price / sales | 4.9× | 14.5× |
| Net cash | $189.5M | $151.8M |
| Dividend yield | — | — |
| Volatility (60d) | 46.1% | 75.0% |
| Short % of float | 8.2% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).